Your browser doesn't support javascript.
loading
Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial.
Dal Lago, Lissandra; Uwimana, Aimé Lambert; Coens, Corneel; Vuylsteke, Peter; Curigliano, Giuseppe; Brouwers, Barbara; Jagiello-Gruszfeld, Agnieszka; Altintas, Sevilay; Tryfonidis, Konstantinos; Poncet, Coralie; Bottomley, Andrew; Sousa, Berta; Brain, Etienne; Wildiers, Hans.
Afiliação
  • Dal Lago L; Institut Jules Bordet, Department of Medicine, Université Libre de Bruxelles, 1 Rue Héger Bordet, 1000 Brussels, Belgium. Electronic address: lissandra.dallago@bordet.be.
  • Uwimana AL; European Organisation of Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Coens C; European Organisation of Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Vuylsteke P; Centre Hospitalier Universitaire, Site Sainte-Elisabeth, UCLouvain, Namur, Belgium; University of Botswana, Gaborone, Botswana.
  • Curigliano G; Department of Hematology and Oncology, Division of Early Drug Development, University of Milano, Istituto Europeo di Oncologia, IRCCS, Milan, Italy.
  • Brouwers B; Department of General Medical Oncology, University Hospitals Leuven and Department of Oncology, KU Leuven, Leuven, Belgium.
  • Jagiello-Gruszfeld A; Maria Sklodowska-Curie National Research Institute of Oncology, Poland.
  • Altintas S; Department of Medical Oncology, Antwerp University Hospital, Antwerp, Belgium.
  • Tryfonidis K; European Organisation of Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Poncet C; European Organisation of Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Bottomley A; European Organisation of Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Sousa B; Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.
  • Brain E; Department of Medical Oncology, Institut Curie (Hôpital René Huguenin) Saint-Cloud, France.
  • Wildiers H; Department of General Medical Oncology, University Hospitals Leuven and Department of Oncology, KU Leuven, Leuven, Belgium.
J Geriatr Oncol ; 13(5): 582-593, 2022 06.
Article em En | MEDLINE | ID: mdl-35101364
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias da Mama Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans Idioma: En Revista: J Geriatr Oncol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias da Mama Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans Idioma: En Revista: J Geriatr Oncol Ano de publicação: 2022 Tipo de documento: Article